New Proteins Linked to Epilepsy Risk and Treatment Options
Source: Clinical neurology and neurosurgery
Summary
Researchers studied the relationship between plasma proteins and epilepsy to understand how certain proteins might influence the risk of developing this condition. They used advanced techniques to analyze data from large studies that looked at genetic information. The focus was on identifying proteins that could either increase or decrease the risk of epilepsy and its different types.
The study found that two proteins, GZMA and TFF1, were linked to a higher risk of epilepsy, while three other proteins, SHBG, CCL15, and ACE, were associated with a lower risk. Specifically, CCL15 and NQO1 were connected to a reduced risk of focal epilepsy, while GZMA was linked to an increased risk of this type. For generalized epilepsy, 16 proteins showed significant connections, suggesting that these proteins could play important roles in the disease.
This research is important because it could lead to new ways to diagnose and treat epilepsy by focusing on these proteins. However, the findings are still early, and more studies are needed to confirm how these proteins work and how they can be used in clinical settings. Understanding these relationships better could help improve care for people with epilepsy in the future.
Free: Seizure First Aid Quick Guide (PDF)
Plus one plain-language weekly digest of new epilepsy research.
Unsubscribe anytime. No medical advice.
